Decreased density of β-adrenergic receptors on peripheral blood mononuclear cells in patients with atopic dermatitis

European Journal of Dermatology

Volumn 6, Issue 5, 1996, Pages 377-380

  Niemeier, Volker ^a   Gieler, Uwe ^a   Baerwald, Christoph ^b   Kupfer, Jörg ^a   Schill, Wolf Bernhard ^a   Happle, Rudolf ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

2 adrenergic receptors; Atopic dermatitis; Lymphocytes; Psychoimmunology; sIL 2R

Indexed keywords

BETA ADRENERGIC RECEPTOR; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PSYCHOLOGICAL ASPECT;

EID: 0029955843     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. 3H]alprenolol binding. J Clin Invest 1976; 57: 149-55.
2. 2-adrenoceptors, accelerated restoration of β-adrenoceptor responsiveness by Prednisone and Ketotifen. J Clin Invest 1985; 76: 1096-101.
3. Khan MM, Sansoni P, Silverman ED, et al. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem Pharmacol 1986; 35: 1137-42.
4. Felten DL, Felten SY, Bellinger DL, et al. Noradrenergic sympathetic neural interactions with the immune system; structure and function. Immunol Rev 1987; 100: 225-60.
5. Cavagnaro J, Waterhouse GAW, Lewis RM. Neuroendocrine-immune interactions: immunoregulatory signals mediated by neurohumoral agents. In: Crus JM, Lewis RM, et al. The year in immunology. Basel: Karger 1988; 3: 228-46.
6. Fuchs BA, Campbell KS, Munson AE. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral response in vivo and vitro. Cell Immunol 1988; 117: 339-51.
7. Bourne HR, Lichtenstein IM, Melmon KL, et al. Modulation of inflammation and immunity by cyclic AMP. Science 1974; 184: 19-28.
8. 2-adrenergic, spleen-dependent process. Am J Physiol 1990; 258: E191-E202.
9. Katz P, Zaytoun AM, Fauci AS. Mechanism of human cell mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides. J Immunol 1982; 129: 287-96.
10. Feldman RD, Hunninghake GW, McArdle WL. β-adrenergic receptor-mediated suppression of interleukin-2 receptors in human lymphocytes. J Immunol 1987; 139: 3355-9.
11. Kishimoto T, Ishizaka K. Regulation of the antibody response in vitro. X. Biphasic effect of cyclic AMP on the secondary anti-hapten antibody response to antiimmunoglobulin and enhancing soluble factor. J Immunol 1976; 116: 534-41.
12. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol [suppl] (Stockholm) 1980; 92: 44-7.
13. Stalder JF, Taïeb A. Severity scoring of atopic dermatitis: the scorad index. Dermatol 1993; 186: 23-31.
14. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21 (suppl 97): 77-89.
15. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660-72.
16. Product Description: cellfree, interleukin-2 receptor test kit (T cell sciences).
17. Kapp A, Neuner P, Krutman J, Luger TA, Schöpf E. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels. Acta Derm Venereol 1991; 71 (5): 403-6.
18. Mäki T, Kontula K, Härkönen M. The beta-adrenergic system in man: physiological and pathophysiological response. Regulation of receptor density and functioning. Scand J Clin Lab Invest 1990; 50 (suppl 201): 25-43.
19. Malec P, Nowak Z. Propranolol enhances in vitro interleukin-2 receptor expression on human lymphocytes. Immunol Letters 1988; 17: 319-22.
20. Pochet R, Delespesse G, De Maubeuge J. Characterization of β-adrenoreceptors on intact circulating lymphocytes from patients with atopic dermatitis. Acta Derm Venereol [suppl] (Stockholm) 1980; 92: 26-9.
21. Baerwald C, Graefe G, Wichert von P, et al. Decreased density of β-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J Rheumatol 1992; 19: 204-10.
22. Ballieux RE. Bidirectional communication between the brain and the immune system. Eur J Clin Invest 1992; 22 (suppl 1): 6-9.
23. Reed CE, Busse WW, Lee TP. The adrenergic mechanism and the adenyl cyclase system in atopic dermatitis. J Invest Dermatol 1976; 67: 333-8.
24. Szentivany A. The beta-adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy Clin Immunol 1968; 42: 203-32.
25. Ring J. Zyklisches Adenosin 3-5-Monophosphat (cAMP) und allergie. Hautorzt 1978; 29: 625-31.
26. Ring J. Atopic dermatitis: a disease of general vasoactive mediator dysregulation. Int Arch Allergy Appl Immunol 1979; 59: 233-9.
27. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990; 113: 619-27.
28. Landmann R. Beta-adrenergic receptors in human leukocyte subpopulations. Eur J Clin Invest 1992; 22 (suppl 1): 30-6.